×
AllNewsImagesMaps Videos Shopping Books
Search tools
Did you mean: Santen Pharma

Santen Pharmaceutical Co., Ltd.'s (TSE:4536) Stock Has Shown Weakness Lately But Financial Prospects Look ...

Simply Wall St
Santen Pharmaceutical (TSE:4536) has had a rough three months with its share price down 2.3%. However, stock prices are...
2 weeks ago

Aptar Pharma Launches Ophthalmic Squeeze Dispenser in Europe

Aptar
Aptar Pharma is pleased to announce that its innovative, preservative-free multidose Ophthalmic Squeeze Dispenser has been launched with Santen's...
4 months ago

Santen Agrees to Licensing Agreements and Asset Transfer for its Pharmaceutical Products in North America

Business Wire
Santen Agrees to Licensing Agreements and Asset Transfer for its Pharmaceutical Products in North America ... OSAKA, Japan--(BUSINESS WIRE)--...
9 months ago

Santen sells North American ophthalmic portfolio to Visiox, Harrow

BioWorld MedTech
Santen Pharmaceutical Co. Ltd. is selling its North American branded ophthalmic portfolio to Visiox Pharma LLC and Harrow Health Inc. in a...
9 months ago

Open-Angle Glaucoma Market Size and Share to Accelerate Substantially by 2032, Predicts DelveInsight | Key ...

PR Newswire
PRNewswire/ -- DelveInsight's Open-Angle Glaucoma Market Insights report includes a comprehensive understanding of current treatment...
6 months ago

Santen Pharmaceutical Co., Ltd. (TSE:4536) Is About To Go Ex-Dividend, And It Pays A 2.2% Yield

Simply Wall Street
The Bottom Line. Is Santen Pharmaceutical an attractive dividend stock, or better left on the shelf? Earnings per share are down meaningfully,...
1 month ago

Glaucoma Market to Accelerate Substantially During the Forecast Period (2023–2032), Examines DelveInsight ...

GlobeNewswire
The dynamics of the glaucoma market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies,...
5 months ago

Santen Publish Results From MERCURY-3 Trial

European Pharmaceutical Manufacturer
Results in Graefe's Archive for Clinical and Experimental Ophthalmology, from the MERCURY-3 trial support the addition of Roclanda as an...
7 months ago

A conversation with Santen's CIO: What does an IT organisation need to survive and win in the global market? (Part 1)

PwC
Santen Pharmaceutical Co., Ltd. (hereinafter 'Santen') has been striving to contribute to the optical health of people around the world for...
15 months ago

Glaukos expands microshunt licensing agreement with Santen Pharmaceuticals

Drug Delivery Business
San Clemente, Calif.-based Glaukos' agreement with Santen Pharmaceutical supersedes the previous collaboration and distribution agreements...
35 months ago